Giacobello Scott M. 4
4 · Aadi Bioscience, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-03-03$2.35/sh−2,806$6,594→ 23,944 total - Exercise/Conversion
Common Stock
2025-03-01+6,750→ 26,750 total - Exercise/Conversion
Restricted Stock Units
2025-03-01−6,750→ 20,250 total→ Common Stock (6,750 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
- [F2]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.